This product is not intended to diagnose, mitigate, treat, cure or prevent any disease.
Moreover, it lowers the risk of major cardiovascular events including heart attacks in some people
But these are new drugs with unknown long-term consequences
June 2024 Update: The latest docket report from the Judicial Panel on Multidistrict Litigation (JPML) indicates that there are currently 101 lawsuits filed against the manufacturers of Ozempic and other GLP-1 agonist drugs in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation
CLICK HERE TO GET THE FOX NEWS APP The new drugs active ingredient is liraglutide instead of Ozempics semaglutide and it is approved for use in both adults and children age 10 and older who have diabetes
#FC-121-2001, San Diego, USA) and sequenced for 500+7 cycles on Illumina MiSeq using the MiSeq Reagent Kit (500 cycles-PE, cat